Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA LUPIN NATCO PHARMA/
LUPIN
 
P/E (TTM) x 13.3 40.7 32.7% View Chart
P/BV x 3.5 6.0 58.4% View Chart
Dividend Yield % 0.6 0.2 233.8%  

Financials

 NATCO PHARMA   LUPIN
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
LUPIN
Mar-23
NATCO PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs847799 106.0%   
Low Rs502583 86.1%   
Sales per share (Unadj.) Rs148.4365.8 40.6%  
Earnings per share (Unadj.) Rs39.29.8 398.4%  
Cash flow per share (Unadj.) Rs48.229.2 165.0%  
Dividends per share (Unadj.) Rs5.504.00 137.5%  
Avg Dividend yield %0.80.6 140.9%  
Book value per share (Unadj.) Rs267.1270.7 98.7%  
Shares outstanding (eoy) m182.47454.98 40.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.51.9 240.6%   
Avg P/E ratio x17.270.2 24.5%  
P/CF ratio (eoy) x14.023.7 59.1%  
Price / Book Value ratio x2.52.6 98.9%  
Dividend payout %14.040.7 34.5%   
Avg Mkt Cap Rs m123,049314,381 39.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4,86730,872 15.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,071166,417 16.3%  
Other income Rs m1,2851,509 85.2%   
Total revenues Rs m28,356167,926 16.9%   
Gross profit Rs m9,11717,206 53.0%  
Depreciation Rs m1,6388,807 18.6%   
Interest Rs m1452,743 5.3%   
Profit before tax Rs m8,6197,165 120.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4662,688 54.5%   
Profit after tax Rs m7,1534,477 159.8%  
Gross profit margin %33.710.3 325.7%  
Effective tax rate %17.037.5 45.3%   
Net profit margin %26.42.7 982.2%  
BALANCE SHEET DATA
Current assets Rs m30,003124,513 24.1%   
Current liabilities Rs m6,83192,654 7.4%   
Net working cap to sales %85.619.1 447.1%  
Current ratio x4.41.3 326.8%  
Inventory Days Days6326 242.1%  
Debtors Days Days11598 117.5%  
Net fixed assets Rs m26,571103,490 25.7%   
Share capital Rs m365910 40.1%   
"Free" reserves Rs m48,373122,246 39.6%   
Net worth Rs m48,738123,156 39.6%   
Long term debt Rs m0275 0.0%   
Total assets Rs m56,574228,003 24.8%  
Interest coverage x60.43.6 1,673.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.7 65.6%   
Return on assets %12.93.2 407.4%  
Return on equity %14.73.6 403.7%  
Return on capital %18.08.0 224.0%  
Exports to sales %00-   
Imports to sales %10.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,772NA-   
Fx inflow Rs m17,25648,057 35.9%   
Fx outflow Rs m2,77221,752 12.7%   
Net fx Rs m14,48426,306 55.1%   
CASH FLOW
From Operations Rs m8,49118,972 44.8%  
From Investments Rs m-4,771-12,868 37.1%  
From Financial Activity Rs m-3,630-3,373 107.6%  
Net Cashflow Rs m2082,732 7.6%  

Share Holding

Indian Promoters % 49.7 46.8 106.3%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 25.0 45.8 54.5%  
FIIs % 13.7 16.1 85.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 53.0 95.0%  
Shareholders   207,571 281,542 73.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Lupin Share Price Performance

Period Natco Pharma Lupin S&P BSE HEALTHCARE
1-Day -2.11% 1.23% 1.18%
1-Month -3.19% 0.15% -0.75%
1-Year 72.80% 151.14% 61.82%
3-Year CAGR 4.96% 17.13% 18.16%
5-Year CAGR 10.96% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.